AS
TMCI icon

Altshuler Shaham’s Treace Medical Concepts TMCI Stock Holding History

Altshuler Shaham’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,097
Closed -$25.2K – 459
2022
Q4 		$25.2K Buy
+1,097
New +$25.3K ﹤0.01% 340

Other funds holding TMCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Altshuler Shaham's TMCI Position: Q1 2023 in Review

Altshuler Shaham sold out of Treace Medical Concepts (TMCI) in Q1 2023, closing a stake of 1,097 shares — an estimated $25.2K sold.

Altshuler Shaham first reported a position in TMCI in Q4 2022 and held it in 1 quarter. The position peaked at $25.2K in Q4 2022. 123 funds tracked by Wall St. Rank hold TMCI as of Q1 2023.

  • Altshuler Shaham reported no remaining Treace Medical Concepts position as of Q1 2023 after selling out during the quarter.
  • Altshuler Shaham sold 1,097 Treace Medical Concepts shares in Q1 2023, an estimated $25.2K.
  • Altshuler Shaham first reported a position in Treace Medical Concepts in Q4 2022 and held it in 1 quarter.
  • Altshuler Shaham's Treace Medical Concepts position peaked at $25.2K in Q4 2022.
  • 123 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2023.

Based on Altshuler Shaham's 13F filing for Q1 2023, filed 9 May 2023.